119 related articles for article (PubMed ID: 22492839)
1. Acute effects of sildenafil on uroflowmetric parameters in erectile dysfunction patients with and without lower urinary tract symptoms.
Öztürk MI; Koca O; Sertkaya Z; Keles MO; Kaya C; Karaman MI
J Androl; 2012; 33(6):1165-8. PubMed ID: 22492839
[TBL] [Abstract][Full Text] [Related]
2. [Sildenafil assumption and acute effects on the uroflowmetric parameters].
Masciovecchio S; Del Rosso A; Di Pierro ED; Saldutto P; Paradiso Galatioto G; Vicentini C
Minerva Urol Nefrol; 2013 Sep; 65(3):205-9. PubMed ID: 23872631
[TBL] [Abstract][Full Text] [Related]
3. Does sildenafil affect uroflowmetry values in men with lower urinary tract symptoms suggestive of benign prostatic enlargement?
Güler C; Tüzel E; Doğantekin E; Kiziltepe G
Urol Int; 2008; 80(2):181-5. PubMed ID: 18362490
[TBL] [Abstract][Full Text] [Related]
4. Uroflowmetric assessment of acute effects of sildenafil on the voiding of men with erectile dysfunction and symptomatic benign prostatic hyperplasia.
Guven EO; Balbay MD; Mete K; Serefoglu EC
Int Urol Nephrol; 2009; 41(2):287-92. PubMed ID: 18649004
[TBL] [Abstract][Full Text] [Related]
5. Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.
Kaplan SA; Gonzalez RR; Te AE
Eur Urol; 2007 Jun; 51(6):1717-23. PubMed ID: 17258855
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil citrate improves erectile function and lower urinary tract symptoms independent of baseline body mass index or LUTS severity.
McVary KT; Siegel RL; Carlsson M
Urology; 2008 Sep; 72(3):575-9. PubMed ID: 18597830
[TBL] [Abstract][Full Text] [Related]
7. Role of phosphodiesterase type 5 inhibitors for lower urinary tract symptoms.
Miller MS
Ann Pharmacother; 2013 Feb; 47(2):278-83. PubMed ID: 23386068
[TBL] [Abstract][Full Text] [Related]
8. [Medicinal therapy of benign prostate syndrome with phosphodiesterase-5 inhibitors].
Herlemann A; Gratzke C; Andersson KE; Sievert KD
Urologe A; 2013 Feb; 52(2):204-11. PubMed ID: 23417046
[TBL] [Abstract][Full Text] [Related]
9. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial.
Spitzer M; Basaria S; Travison TG; Davda MN; Paley A; Cohen B; Mazer NA; Knapp PE; Hanka S; Lakshman KM; Ulloor J; Zhang A; Orwoll K; Eder R; Collins L; Mohammed N; Rosen RC; DeRogatis L; Bhasin S
Ann Intern Med; 2012 Nov; 157(10):681-91. PubMed ID: 23165659
[TBL] [Abstract][Full Text] [Related]
10. Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment.
Roehrborn CG; Kaminetsky JC; Auerbach SM; Montelongo RM; Elion-Mboussa A; Viktrup L
BJU Int; 2010 Feb; 105(4):502-7. PubMed ID: 19732051
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of sildenafil citrate in patients with erectile dysfunction and lower urinary system symptoms and the significance of asymptomatic inflammatory prostatitis.
Eryildirim B; Aktas A; Kuyumcuoglu U; Faydaci G; Tarhan F; Ozgül A
Int J Impot Res; 2010; 22(6):349-54. PubMed ID: 20981108
[TBL] [Abstract][Full Text] [Related]
12. [The positive effect of sildenafil on LUTS from BPH while treating ED].
Ying J; Yao D; Jiang Y; Ren X; Xu M
Zhonghua Nan Ke Xue; 2004 Sep; 10(9):681-3. PubMed ID: 15497711
[TBL] [Abstract][Full Text] [Related]
13. Male lower urinary tract symptoms and sildenafil.
Jackson G
Int J Clin Pract; 2007 Nov; 61(11):1779. PubMed ID: 17935539
[No Abstract] [Full Text] [Related]
14. [Effects of phosphodiesterase type 5 inhibitors on lower urinary tract symptoms secondary to benign prostatic hyperplasia].
Giuliano F; Rouprêt M; Doridot G; de la Taille A
Prog Urol; 2013 Apr; 23(5):283-95. PubMed ID: 23545003
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of alfuzosin and sildenafil combination in male patients with lower urinary tract symptoms.
Öztürk Mİ; Kalkan S; Koca O; Güneş M; Akyüz M; Karaman MI
Andrologia; 2012 May; 44 Suppl 1():791-5. PubMed ID: 22211956
[TBL] [Abstract][Full Text] [Related]
16. Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies.
Brock GB; McVary KT; Roehrborn CG; Watts S; Ni X; Viktrup L; Wong DG; Donatucci C
J Urol; 2014 Feb; 191(2):405-11. PubMed ID: 24096120
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of on-demand Elonza; a generic product of sildenafil in Thai men with erectile dysfunction.
Wijitsettakul U; Pempongkosol S
J Med Assoc Thai; 2013 Jun; 96(6):683-8. PubMed ID: 23951825
[TBL] [Abstract][Full Text] [Related]
18. Effects of tadalafil once daily on maximum urinary flow rate in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Roehrborn CG; Chapple C; Oelke M; Cox D; Esler A; Viktrup L
J Urol; 2014 Apr; 191(4):1045-50. PubMed ID: 24445278
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.
Porst H; Kim ED; Casabé AR; Mirone V; Secrest RJ; Xu L; Sundin DP; Viktrup L;
Eur Urol; 2011 Nov; 60(5):1105-13. PubMed ID: 21871706
[TBL] [Abstract][Full Text] [Related]
20. Assisted semen collection using two phosphodiesterase type 5 inhibitors (Tadalafil and Sildenafil) in infertile men with mild erectile dysfunction.
Tang WH; Liu DF; Jiang H; Ma LL; Hong K; Zhao LM; Mao JM; Yang Y; Zhang J; Gao L; Zhuang XJ; Qiao J
Chin Med J (Engl); 2013 Jul; 126(14):2788-9. PubMed ID: 23876915
[No Abstract] [Full Text] [Related]
[Next] [New Search]
